Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
Abstract
The current management of hyperphosphatemia with phosphate binders is associated with insufficient phosphorus control and a significant pill burden. Tenapanor, a first-in-class, phosphate absorption inhibitor, is expected to control phosphorus and decrease pill burden because of its small pill size and twice daily dosing regimen. This study evaluated tenapanor effectiveness on reducing the phosphate binder pill burden during a 26-week treatment...
Paper Details
Title
Effect of Tenapanor on Phosphate Binder Pill Burden in Hemodialysis Patients
Published Date
Sep 1, 2021
Journal
Volume
6
Issue
9
Pages
2371 - 2380
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History